Research explained: randomized controlled trial
With the same 10% weight loss, a very low carb keto diet improved liver metabolism more than Mediterranean or very low fat diets, a trial finds
A randomized trial in Cell Metabolism compared three popular diets in people with obesity, prediabetes and a fatty liver. All three groups lost about 10% of their weight and gained about 50% in muscle insulin sensitivity, but the keto group saw a two to three times larger gain in liver insulin sensitivity. LDL cholesterol did not differ between diets.
When people with obesity, prediabetes and a fatty liver lost about 10% of their body weight, a very low carbohydrate ketogenic diet improved how the liver handles insulin two to three times more than a Mediterranean diet or a very low fat, plant-forward diet, according to a randomized trial in Cell Metabolism (published online August 27, 2026, in the October 6 issue). Fat stored in the liver, blood sugar and insulin also fell most on keto. Muscle insulin sensitivity rose by about 50% in all three groups, and LDL cholesterol did not differ between the diets. The trial drew wide news coverage again this week.
What the researchers did
A team at Washington University School of Medicine in St. Louis randomly assigned adults with what they call metabolically unhealthy obesity to one of three diets: very low carb ketogenic, Mediterranean, or very low fat and plant-forward. The goal was a similar, moderate weight loss of about 10% in every group, after which the researchers measured insulin sensitivity in muscle and liver, fat stored inside the liver, how much new fat the liver was making, blood sugar markers and blood fats.
How strong is the evidence?
This is a randomized trial, and matching the weight loss across groups helps separate the effect of the diet itself from the effect of losing weight. Still, news reports describe the trial as small, the abstract does not give the number of participants, and it included only people who already had prediabetes and a fatty liver, so the results may not apply to everyone. It measured blood and liver markers, not long-term outcomes such as diabetes or heart disease. The senior author reported advisory board fees from AbbVie, 89Bio and Boehringer Ingelheim, a grant from Merck, and support for a trial sponsored by Viking Therapeutics.
What it means for you
All three diets led to real improvements once weight came down, so the diet you can stick with matters most. If you have a fatty liver or prediabetes, cutting back on refined carbs may give your liver extra help; a lower carb plate can still lean on olive oil, avocado and salmon. If you prefer a Mediterranean or plant-forward style, foods like lentils fit well. Before starting strict keto, talk with your doctor, especially if you take blood sugar medicine.